ALP (U/L) | Ferritin (ng/mL) | GGT (U/L) | |||||||||
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
Baseline | 67.7 ± 24.2 | 89.9 ± 32.6a,b | 68.5 ± 22.1 | Baseline | 91.1 ± 75.2 | 67.2 ± 57.2 | 71.6 ± 71.6 | Baseline | 17.9 ± 12.4 | 13.4 ± 8.4 | 14.2 ± 7.6 |
Week 4 | 73.1 ± 17.0 | 76.3 ± 21.6 | 66.0 ± 20.5 | Week 4 | 77.0 ± 82.3 | 62.1 ± 46.6 | 76.0 ± 74.1 | Week 4 | 19.5 ± 11.4 | 13.7 ± 13.3 | 16.2 ± 8.4 |
Week 8 | 71.9 ± 19.4 | 82.9 ± 25.9a,b | 59.6 ± 23.1 | Week 8 | 80.8 ± 76.3 | 49.6 ± 40.0 | 75.2 ± 85.3 | Week 8 | 17.2 ± 7.7 | 12.7 ± 8.4 | 16.4 ± 9.8 |
Change | 4.3 ± 28.1 | −7.1 ± 32.5 | −8.8 ± 32.7 | Change | −10.2 ± 30.1 | −17.6 ± 48.1 | 3.6 ± 25.9 | Change | −0.7 ± 8.6 | −0.7 ± 5.6 | 2.2 ± 7.2 |
ALT (U/L) | IgA (mg/dL) | Glucose (mmol/L) | |||||||||
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
Baseline | 19.7 ± 10.2 | 17.2 ± 6.3 | 16.7 ± 6.2 | Baseline | 277.7 ± 69.3 | 335.3 ± 76.2 | 318.6 ± 73.2 | Baseline | 5.4 ± 0.4 | 5.3 ± 0.6 | 5.4 ± 0.5 |
Week 4 | 17.0 ± 8.3 | 18.4 ± 10.4 | 17.7 ± 6.4 | Week 4 | 274.7 ± 70.9 | 354.8 ± 42.8 | 322.3 ± 72.7 | Week 4 | 5.5 ± 0.6 | 5.4 ± 0.8 | 5.3 ± 0.7 |
Week 8 | 19.3 ± 8.2 | 15.5 ± 5.7 | 18.6 ± 11.8 | Week 8 | 280.4 ± 67.6 | 334.5 ± 76.6 | 319.7 ± 74.5 | Week 8 | 5.6 ± 0.4 | 5.3 ± 0.6 | 5.3 ± 0.5 |
Change | −0.4 ± 11.5 | −1.7 ± 6.3 | 1.9 ± 11.5 | Change | 2.7 ± 19.6 | −0.9 ± 18.8 | 1.1 ± 20.7 | Change | 0.1 ± 0.4 | 0.0 ± 0.4 | −0.1 ± 0.3 |
AST (U/L) | IgM (mg/dL) | hsCRP (mg/L) | |||||||||
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
Baseline | 23.6 ± 8.4 | 22.9 ± 5.8 | 22.6 ± 4.2 | Baseline | 199.7 ± 48.2 | 206.7 ± 51.8 | 199.1 ± 51.2 | Baseline | 2.2 ± 3.4 | 3.6 ± 4.6 | 1.6 ± 3.7 |
Week 4 | 22.6 ± 6.5 | 23.1 ± 4.9 | 25.4 ± 5.5 | Week 4 | 198.9 ± 46.2 | 190.7 ± 57.0 | 194.9 ± 62.5 | Week 4 | 1.6 ± 2.4 | 2.4 ± 3.4 | 2.4 ± 4.6 |
Week 8 | 33.8 ± 42.5 | 22.1 ± 5.6 | 23.8 ± 5.1 | Week 8 | 205.4 ± 43.4 | 203.8 ± 57.8 | 196.5 ± 49.2 | Week 8 | 1.6 ± 3.0 | 2.7 ± 4.2 | 1.7 ± 3.2 |
Change | −0.5 ± 6.5 | −0.8 ± 3.7 | 1.3 ± 4.5 | Change | 5.8 ± 26.9 | −2.9 ± 30.2 | −2.6 ± 19.5 | Change | −0.6 ± 1.5 | −0.9 ± 3.0 | −0.1 ± 1.2 |
Fe (umol/L) | IgG (g/L) |
|
|
|
| ||||||
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
|
|
|
|
Baseline | 12.2 ± 4.7 | 12.6 ± 6.9 | 9.9 ± 4.3 | Baseline | 16.4 ± 2.1 | 16.6 ± 2.6 | 17.3 ± 3.3 |
|
|
|
|
Week 4 | 10.6 ± 3.4 | 8.9 ± 5.0 | 11.3 ± 4.7 | Week 4 | 16.3 ± 2.2 | 16.4 ± 2.1 | 16.9 ± 3.1 |
|
|
|
|
Week 8 | 10.0 ± 5.1 | 9.1 ± 3.4 | 10.5 ± 6.3 | Week 8 | 16.1 ± 2.2 | 16.3 ± 2.3 | 16.8 ± 3.1 |
|
|
|
|
Change | −2.2 ± 6.9 | −3.5 ± 7.1a | 0.6 ± 3.6 | Change | −0.2 ± 0.8 | −0.3 ± 0.8 | −0.5 ± 0.6 |
|
|
|
|